Core Viewpoint - Jinxin Reproductive Medicine (01951.HK) announced a share buyback on December 8, 2023, spending HKD 14.849 million to repurchase 5.929 million shares at a price range of HKD 2.47 to HKD 2.58 per share [1] Summary by Category - **Company Actions** - The company executed a buyback of 5.929 million shares, indicating a strategic move to enhance shareholder value [1] - The total expenditure for the buyback was HKD 14.849 million, reflecting the company's commitment to returning capital to shareholders [1] - **Share Price Information** - The repurchase price per share ranged from HKD 2.47 to HKD 2.58, which may suggest the company's valuation perspective on its own shares [1]

锦欣生殖(01951)发布公告，于2025年12月8日，该公司斥资1484.91万港元回购592.85万股股份，每股回 购价格为2.47-2.58港元。 ...

智通财经APP讯，锦欣生殖(01951)发布公告，于2025年12月8日，该公司斥资1484.91万港元回购592.85 万股股份，每股回购价格为2.47-2.58港元。 ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 呈交日期： 2025年12月8日 公司名稱： 錦欣生殖醫療集團有限公司 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 01951 | 說明 | | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | | | | | 事件 | 已發行股份（不 ...

Core Insights - The Shenzhen-Hong Kong Stock Connect Medical Index (983036) closed at 4406.89 points, down 0.24%, with a trading volume of HKD 7.939 billion and a turnover rate of 0.88% [1] - Among the index constituents, 23 stocks rose while 34 stocks fell, with Yiyang Sunshine leading the gainers at 3.98% and Jinxin Fertility leading the decliners at 3.89% [1] Index Constituents Summary - The top ten constituents of the Shenzhen-Hong Kong Stock Connect Medical Index are as follows: - Mindray Medical (sz300760) holds a weight of 14.56%, latest price at HKD 200.05, down 1.16%, with a market cap of HKD 242.549 billion [1] - Aier Eye Hospital (sz300015) has a weight of 11.62%, latest price at HKD 11.40, up 0.89%, with a market cap of HKD 106.31 billion [1] - Lepu Medical (sz300003) has a weight of 4.85%, latest price at HKD 15.89, up 0.38%, with a market cap of HKD 29.292 billion [1] - Aimeike (sz300896) has a weight of 4.80%, latest price at HKD 142.81, down 0.11%, with a market cap of HKD 43.213 billion [1] - Yuyue Medical (sz002223) has a weight of 4.66%, latest price at HKD 35.84, down 0.83%, with a market cap of HKD 35.929 billion [1] - Yingke Medical (sz300677) has a weight of 3.64%, latest price at HKD 43.72, up 0.97%, with a market cap of HKD 28.644 billion [1] - Furuide (sz300049) has a weight of 3.59%, latest price at HKD 70.75, up 0.71%, with a market cap of HKD 18.747 billion [1] - Meinian Onehealth (sz002044) has a weight of 3.58%, latest price at HKD 5.13, down 0.58%, with a market cap of HKD 20.08 billion [1] - Sinopharm (hk01099) has a weight of 3.35%, latest price at HKD 18.51, down 0.97%, with a market cap of HKD 57.767 billion [1] - Ping An Good Doctor (hk01833) has a weight of 2.63%, latest price at HKD 13.18, up 0.21%, with a market cap of HKD 28.495 billion [1] Capital Flow Analysis - The index constituents experienced a net outflow of main funds totaling HKD 230 million, while retail investors saw a net inflow of HKD 268 million [1] - Detailed capital flow for specific stocks shows: - Furuide (sz300049) had a main fund net inflow of HKD 8.7323 million, with retail outflows of HKD 3.3726 million [2] - Aier Eye Hospital (sz300015) had a main fund net inflow of HKD 6.6536 million, with retail outflows of HKD 1.8752 million [2] - Lepu Medical (sz300003) had a main fund net inflow of HKD 3.7716 million, with retail outflows of HKD 0.7273 million [2]

Core Insights - Multiple companies, including Tencent Holdings and China Petroleum & Chemical Corporation, conducted share buybacks on December 5, 2025, with Tencent leading in both volume and monetary value [1][2] Company Summaries - **Tencent Holdings (00700)**: Repurchased 1.046 million shares for a total of 636 million, with a year-to-date total of 85.148 million shares, representing 0.927% of total share capital [2] - **China National Offshore Oil Corporation (01919)**: Bought back 3 million shares for 41.6745 million, with a cumulative total of 6.9543 million shares, accounting for 2.415% of total share capital [2] - **Kuaishou-W (01024)**: Acquired 438,000 shares for 29.9859 million, with a year-to-date total of 682,460 shares, representing 0.159% of total share capital [2] - **Fenbi (02469)**: Conducted a buyback of 6.657 million shares for 21.0954 million, with a cumulative total of 26.657 million shares, accounting for 1.193% of total share capital [2] - **Jinxin Fertility (01951)**: Repurchased 7.722 million shares for 19.7977 million, with a total of 7.722 million shares year-to-date, representing 0.280% of total share capital [2] - **Yum China (09987)**: Engaged in two buybacks, totaling 57,000 shares for 19.1905 million, with a cumulative total of 16.2024 million shares, accounting for 4.350% of total share capital [2] - **China Feihe (06186)**: Bought back 3 million shares for 12.3 million, with a cumulative total of 208 million shares, representing 2.295% of total share capital [2] - **Haier Smart Home (06690)**: Acquired 450,000 shares for 12.1991 million, with a total of 330,000 shares year-to-date, representing 0.116% of total share capital [2] - **Vitasoy International (00345)**: Repurchased 1.302 million shares for 8.6504 million, with a cumulative total of 1.928 million shares, accounting for 1.837% of total share capital [2] - **Coolpad Group (02369)**: Conducted a buyback of 4.144 million shares for 5.5725 million, with a total of 15.048 million shares year-to-date, representing 3.925% of total share capital [2]

Group 1 - On December 5, 46 Hong Kong-listed companies conducted share buybacks, totaling 43.67 million shares and an aggregate amount of HKD 854 million [1][2] - Tencent Holdings repurchased 1.046 million shares for HKD 636 million, with a year-to-date total buyback amount of HKD 69.865 billion [1][2] - China COSCO Shipping repurchased 3 million shares for HKD 41.67 million, with a year-to-date total buyback amount of HKD 6.113 billion [1][2] - Kuaishou Technology repurchased 438,000 shares for HKD 29.99 million, with a year-to-date total buyback amount of HKD 2.395 billion [1][2] Group 2 - The highest buyback amount on December 5 was from Tencent Holdings at HKD 636 million, followed by China COSCO Shipping at HKD 41.67 million [1][2] - The largest number of shares repurchased on December 5 was by Jinxin Fertility, with 7.722 million shares, followed by Chalk Education and Anton Oilfield Services with 6.657 million and 5.586 million shares, respectively [1][2] - Notably, Jinxin Fertility and Green Tea Group conducted their first buybacks of the year on this date [2]

Group 1 - The core point of the article highlights that southbound funds have reduced their holdings in Jinxin Fertility (01951.HK) by 2.3765 million shares on December 5, 2025, marking a decrease of 0.16% [1] - Over the past five trading days, there have been three days of net reductions in holdings, totaling 8.117 million shares [1] - In the last 20 trading days, southbound funds have increased their holdings on 14 days, with a cumulative net increase of 32.1168 million shares [1] Group 2 - As of December 5, 2025, southbound funds hold a total of 1.474 billion shares of Jinxin Fertility, which represents 53.43% of the company's issued ordinary shares [1] - The company primarily provides in vitro fertilization (IVF) services and operates through subsidiaries that offer assisted reproductive services, management services, mobile surgical center facilities, and sales of medical consumables and equipment [2] - Jinxin Fertility operates mainly in China and the United States, focusing on reproductive health and related medical services [2]

Group 1 - The core point of the article is that Jinxin Reproductive Medicine announced a share buyback on December 5, purchasing 7.722 million shares at a price range of HKD 2.550 to HKD 2.580 per share, totaling HKD 19.7977 million [1][2] - The closing price of the stock on the same day was HKD 2.570, reflecting an increase of 2.80% [1] - The total trading volume for the day reached HKD 76.2472 million [1]

Summary of Key Points Core Viewpoint - Jinxin Reproductive has conducted a share buyback, indicating confidence in its stock value and potential for future growth [2]. Group 1: Buyback Details - On December 5, 2025, Jinxin Reproductive repurchased 7,722,000 shares at prices ranging from HKD 2.550 to HKD 2.580 [2]. - The total amount spent on the buyback was HKD 19,797,700 [2]. - The stock closed at HKD 2.570 on the same day, reflecting a 2.80% increase in value [2]. Group 2: Market Activity - The total trading volume for Jinxin Reproductive on December 5 was HKD 76,247,200 [2].